These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19890252)

  • 21. Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare.
    Dominick KL; Golightly YM; Jackson GL
    J Rheumatol; 2006 Feb; 33(2):348-54. PubMed ID: 16465668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U.S. Department of Veterans Affairs Enterprise Reference Terminology strategic overview.
    Lincoln MJ; Brown SH; Nguyen V; Cromwell T; Carter J; Erlbaum M; Tuttle M
    Stud Health Technol Inform; 2004; 107(Pt 1):391-5. PubMed ID: 15360841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential drug-drug interactions within Veterans Affairs medical centers.
    Mahmood M; Malone DC; Skrepnek GH; Abarca J; Armstrong EP; Murphy JE; Grizzle AJ; Ko Y; Woosley RL
    Am J Health Syst Pharm; 2007 Jul; 64(14):1500-5. PubMed ID: 17617500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the Veterans Affairs Medical Centers in patient care, surgical education, research and faculty development.
    Longo WE; Cheadle W; Fink A; Kozol R; DePalma R; Rege R; Neumayer L; Tarpley J; Tarpley M; Joehl R; Miller TA; Rosendale D; Itani K
    Am J Surg; 2005 Nov; 190(5):662-75. PubMed ID: 16226937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy practice in the Veterans Administration.
    Cheung A; Sleight SM; Sisson NM
    Am J Hosp Pharm; 1987 Apr; 44(4):747-54. PubMed ID: 3555022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital care and medical services in non-VA facilities--VA. Final rule and regulation.
    Fed Regist; 1993 Jun; 58(110):32445-6. PubMed ID: 10171469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling prescription drug costs: regulation and the role of interest groups in Medicare and the Veterans Health Administration.
    Frakt AB; Pizer SD; Hendricks AM
    J Health Polit Policy Law; 2008 Dec; 33(6):1079-106. PubMed ID: 19038872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
    Cooperberg M; Lubeck DP; Penson D; Mehta SS; Carroll PR; Kane CJ
    J Urol; 2003 Sep; 170(3):905-8. PubMed ID: 12913727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating private sector professional fees for VA providers.
    Roselle G; Render ML; Nugent LB; Nugent GN
    Med Care; 2003 Jun; 41(6 Suppl):II23-32. PubMed ID: 12773824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating VA patient-level expenditures: decision support system estimates and Medicare rates.
    Hendricks AM; Lotchin TR; Hutterer J; Swanson J; Kenneally K;
    Med Care; 2003 Jun; 41(6 Suppl):II111-7. PubMed ID: 12773833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predialysis nephrology care among older veterans using Department of Veterans Affairs or Medicare-covered services.
    Fischer MJ; Stroupe KT; Kaufman JS; O'Hare AM; Browning MM; Huo Z; Hynes DM
    Am J Manag Care; 2010 Feb; 16(2):e57-66. PubMed ID: 20148611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
    Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
    J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
    Chao SD; Maibach HI
    Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring the quality of the VA Health Care System.
    Heidenreich PA
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1793-8. PubMed ID: 15533187
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of frequently used drug interaction screening programs.
    Vonbach P; Dubied A; Krähenbühl S; Beer JH
    Pharm World Sci; 2008 Aug; 30(4):367-74. PubMed ID: 18415695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials.
    Rashdan S; Yang H; Le T; Selby C; Gerber DE; Alvarez CA
    Clin Drug Investig; 2021 Feb; 41(2):161-167. PubMed ID: 33417195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Government. Shinseki exit won't fix VA woes.
    Dickson V; Landen R; Herman B
    Mod Healthc; 2014 Jun; 44(22):8. PubMed ID: 24946371
    [No Abstract]   [Full Text] [Related]  

  • 40. Status report on VA national formulary issued.
    Landis NT
    Am J Health Syst Pharm; 2000 Feb; 57(3):205-6. PubMed ID: 10674768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.